Real-time Estimate
Cboe BZX
10:04:56 2024-05-01 EDT
|
5-day change
|
1st Jan Change
|
11.08
USD
|
-1.12%
|
|
-0.89%
|
-33.71%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
7,802
|
6,663
|
2,350
|
4,762
|
3,170
|
-
|
-
|
Enterprise Value (EV)
1 |
9,560
|
8,341
|
3,976
|
6,767
|
5,103
|
4,956
|
3,170
|
P/E ratio
|
-172
x
|
57.4
x
|
-10
x
|
93.6
x
|
32.8
x
|
21.6
x
|
15.8
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
9.54
x
|
7.15
x
|
2.34
x
|
4.54
x
|
2.88
x
|
2.7
x
|
2.52
x
|
EV / Revenue
|
11.7
x
|
8.95
x
|
3.96
x
|
6.45
x
|
4.64
x
|
4.22
x
|
2.52
x
|
EV / EBITDA
|
22.8
x
|
17.3
x
|
7.85
x
|
12.8
x
|
9.2
x
|
8.27
x
|
4.88
x
|
EV / FCF
|
143
x
|
46.5
x
|
41.6
x
|
-18.7
x
|
24.4
x
|
17
x
|
-
|
FCF Yield
|
0.7%
|
2.15%
|
2.4%
|
-5.36%
|
4.1%
|
5.89%
|
-
|
Price to Book
|
14.4
x
|
11.4
x
|
6.72
x
|
10.7
x
|
6.01
x
|
4.7
x
|
-
|
Nbr of stocks (in thousands)
|
284,321
|
282,917
|
282,113
|
282,623
|
283,071
|
-
|
-
|
Reference price
2 |
27.44
|
23.55
|
8.330
|
16.85
|
11.20
|
11.20
|
11.20
|
Announcement Date
|
21-03-09
|
22-03-01
|
23-02-28
|
24-02-27
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
778.3
|
818.2
|
931.5
|
1,004
|
1,049
|
1,100
|
1,176
|
1,260
|
EBITDA
1 |
-
|
419.9
|
481.2
|
506.2
|
528
|
554.7
|
599.4
|
650.3
|
EBIT
1 |
-
|
356.6
|
417.1
|
442.2
|
451.5
|
481
|
520.3
|
563.4
|
Operating Margin
|
-
|
43.58%
|
44.77%
|
44.06%
|
43.02%
|
43.74%
|
44.25%
|
44.7%
|
Earnings before Tax (EBT)
|
-
|
-38.86
|
175.7
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
-20.85
|
-38.62
|
116.9
|
-233.6
|
51.38
|
97.03
|
148.6
|
207
|
Net margin
|
-2.68%
|
-4.72%
|
12.55%
|
-23.27%
|
4.9%
|
8.82%
|
12.63%
|
16.43%
|
EPS
2 |
-
|
-0.1600
|
0.4100
|
-0.8300
|
0.1800
|
0.3418
|
0.5177
|
0.7100
|
Free Cash Flow
1 |
-
|
67.08
|
179.4
|
95.58
|
-362.7
|
209
|
292
|
-
|
FCF margin
|
-
|
8.2%
|
19.26%
|
9.52%
|
-34.57%
|
19.01%
|
24.83%
|
-
|
FCF Conversion (EBITDA)
|
-
|
15.98%
|
37.28%
|
18.88%
|
-
|
37.67%
|
48.72%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
153.47%
|
-
|
-
|
215.39%
|
196.55%
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20-09-02
|
21-03-09
|
22-03-01
|
23-02-28
|
24-02-27
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
226.2
|
241.2
|
236.8
|
266.6
|
248.7
|
251.6
|
220.6
|
255.3
|
263.2
|
310.2
|
244.6
|
274.6
|
279.5
|
301.3
|
259
|
EBITDA
1 |
116.7
|
124.7
|
115.3
|
136.1
|
125.2
|
129.6
|
98.47
|
128.5
|
134.3
|
166.7
|
116.9
|
138
|
142.7
|
157.5
|
125
|
EBIT
1 |
100.3
|
108
|
99.48
|
120.4
|
109.3
|
113.1
|
79.54
|
109.5
|
116.3
|
146.1
|
97.16
|
120.6
|
124.3
|
138.7
|
103
|
Operating Margin
|
44.34%
|
44.76%
|
42.02%
|
45.15%
|
43.93%
|
44.96%
|
36.06%
|
42.89%
|
44.2%
|
47.09%
|
39.73%
|
43.94%
|
44.47%
|
46.04%
|
39.77%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
27.44
|
36
|
30.64
|
30.42
|
25.09
|
-319.7
|
2.842
|
23.51
|
-13.66
|
38.68
|
11.25
|
28.9
|
31.05
|
41.9
|
20
|
Net margin
|
12.13%
|
14.92%
|
12.94%
|
11.41%
|
10.09%
|
-127.08%
|
1.29%
|
9.21%
|
-5.19%
|
12.47%
|
4.6%
|
10.52%
|
11.11%
|
13.91%
|
7.72%
|
EPS
2 |
0.1000
|
0.1300
|
0.1100
|
0.1100
|
0.0900
|
-1.140
|
0.0100
|
0.0800
|
-0.0500
|
0.1400
|
0.0343
|
0.0812
|
0.0946
|
0.1319
|
0.0700
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
21-11-10
|
22-03-01
|
22-05-05
|
22-08-04
|
22-11-02
|
23-02-28
|
23-05-03
|
23-08-03
|
23-11-01
|
24-02-27
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
1,758
|
1,679
|
1,626
|
2,005
|
1,932
|
1,786
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
4.188
x
|
3.488
x
|
3.212
x
|
3.796
x
|
3.484
x
|
2.98
x
|
-
|
Free Cash Flow
1 |
-
|
67.1
|
179
|
95.6
|
-363
|
209
|
292
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
47.3%
|
57.7%
|
58%
|
38.7%
|
35.1%
|
28.4%
|
ROA (Net income/ Total Assets)
|
-
|
3.71%
|
8.86%
|
9.15%
|
7.37%
|
8.28%
|
9.43%
|
-
|
Assets
1 |
-
|
-1,041
|
1,320
|
-2,553
|
697.1
|
1,171
|
1,575
|
-
|
Book Value Per Share
2 |
-
|
1.900
|
2.070
|
1.240
|
1.570
|
1.860
|
2.380
|
-
|
Cash Flow per Share
|
-
|
0.5100
|
0.3700
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
53.5
|
102
|
182
|
215
|
217
|
171
|
-
|
Capex / Sales
|
-
|
6.54%
|
10.97%
|
18.17%
|
20.49%
|
19.69%
|
14.54%
|
-
|
Announcement Date
|
20-09-02
|
21-03-09
|
22-03-01
|
23-02-28
|
24-02-27
|
-
|
-
|
-
|
Last Close Price
11.2
USD Average target price
16.67
USD Spread / Average Target +48.81% Consensus |
1st Jan change
|
Capi.
|
---|
| -33.71% | 3.17B | | -29.72% | 85.35B | | +13.61% | 81.95B | | +9.37% | 28.99B | | -11.80% | 16.98B | | -0.36% | 16.85B | | -0.36% | 15.35B | | +4.32% | 12.42B | | +30.97% | 12.19B | | -31.40% | 11.89B |
Other Healthcare Facilities & Services
|